| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/20/2001 | US6190877 Placing sample into culutre media, incubating with fluorescent marker while retaining viabilty, activating with light to cause fluorescence, and viewing; fluorescence indicates malignancy or pre-malignancy |
| 02/20/2001 | US6190876 KUZ, a novel family of metalloproteases |
| 02/20/2001 | US6190875 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 02/20/2001 | US6190874 Methods for identifying compounds that bind to CSAPK-1 |
| 02/20/2001 | US6190873 Mixing in aqueous medium the sample, a cyclosporin-label conjugate having specific linking groups, and antibodies capable of binding to cyclosporin-label conjugate; and determining presence of complex |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/20/2001 | US6190869 Antisense inhibition of protein kinase C-theta expression |
| 02/20/2001 | US6190868 Method for identifying a nucleic acid sequence |
| 02/20/2001 | US6190865 Accurate, simple method by amplifying dna using non-canonical deoxynucleoside triphosphate, contacting synthesized dna with an n-glycosylase to excise that base, fragmenting dna at the abasic sites, separating fragments by size |
| 02/20/2001 | US6190864 HCV genomic sequences for diagnostics and therapeutics |
| 02/20/2001 | US6190861 Molecular sequences of swine retroviruses method of using |
| 02/20/2001 | US6190860 Method to detect CMV by hybridization with a gp55 specific DNA probe |
| 02/20/2001 | US6190858 Detection of conditions by analysis of gases or vapors |
| 02/20/2001 | US6190857 Diagnosis of disease state using MRNA profiles in peripheral leukocytes |
| 02/20/2001 | US6190723 Neutralization of food allergens by thioredoxin |
| 02/20/2001 | US6190667 Contacting parental helicobacter strain with molecule in biological sample and contacting helicobacter strain deficient in urei gene with molecule; comparing acidity sensitivity of both strains; selecting molecule that increases acidity |
| 02/20/2001 | US6190662 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 02/20/2001 | US6190661 Methods and compositions for the use of apurinic/apyrimidinic endonucleases |
| 02/20/2001 | US6190522 Analysis of carbohydrates derivatized with visible dye by high-resolution polyacrylamide gel electrophoresis |
| 02/20/2001 | CA2197233C Methods of identifying compounds useful for treating autoimmune diseases |
| 02/20/2001 | CA2176361C Polyhydroxybutyrate and polyphosphate membranes with channels |
| 02/20/2001 | CA2130014C Improved system for detecting bacterial growth in a plurality or culture vials |
| 02/19/2001 | CA2316400A1 Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
| 02/15/2001 | WO2001011533A1 Method of recording gene analysis data |
| 02/15/2001 | WO2001011373A2 Difference detection methods using matched multiple dyes |
| 02/15/2001 | WO2001011369A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | WO2001011367A1 Method of assyaing phosphorylation enzyme activity of cyclin/cdk complex |
| 02/15/2001 | WO2001011366A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 02/15/2001 | WO2001011364A1 Method for automatic labeling using dispenser, method for automatically separating target substance, method for determining base sequence, and automatic dispensing system |
| 02/15/2001 | WO2001011362A1 Cell counting method and kit |
| 02/15/2001 | WO2001011361A2 Kit and method to assess the malignancy of neoplasias |
| 02/15/2001 | WO2001011359A2 Color space analysis in biochemical and immunological assays |
| 02/15/2001 | WO2001011351A1 Method for detecting single nucleotide polymorphism (snp) and point mutation in gene, detection apparatus and detection chip |
| 02/15/2001 | WO2001011340A1 Optical system analysis of cells |
| 02/15/2001 | WO2001011336A1 Direct aspiration-reaction and injection device and methods of use |
| 02/15/2001 | WO2001011333A2 Apparatus for real-time measurement of cellular response |
| 02/15/2001 | WO2001011090A2 Identification of virus-binding polypeptides and nucleotide sequences |
| 02/15/2001 | WO2001011088A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 02/15/2001 | WO2001011086A2 Methods of screening for angiogenesis modulators |
| 02/15/2001 | WO2001011085A2 Bdnf polymorphism and association with bipolar disorder |
| 02/15/2001 | WO2001011084A1 Genetic polymorphism in the il-10 promoter |
| 02/15/2001 | WO2001011083A2 Methods for detecting mutations using primer extension |
| 02/15/2001 | WO2001011082A2 Methods of gene expression monitoring |
| 02/15/2001 | WO2001011081A2 Microbial polynucleotides expressed during infection of a host |
| 02/15/2001 | WO2001011080A1 A printed circuit board, biosensor and method of using same |
| 02/15/2001 | WO2001011079A2 Nucleic acid analysis method and system |
| 02/15/2001 | WO2001011078A1 Amplification method for detection of target nucleic acids involving fluorescence energy transfer |
| 02/15/2001 | WO2001011077A2 Methods of diagnosing or treating irritable bowel syndrome and other disorders |
| 02/15/2001 | WO2001011076A1 In vivo high throughput toxicology screening method |
| 02/15/2001 | WO2001011075A2 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 02/15/2001 | WO2001011071A2 Bioproduction of para-hydroxycinnamic acid |
| 02/15/2001 | WO2001011064A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | WO2001011060A2 Method of isolating secretion signals in lactic acid bacteria and novel secretion signals isolated from lactococcus lactis |
| 02/15/2001 | WO2001011054A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 02/15/2001 | WO2001011051A2 Chimeric proteins |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011047A2 Dna sequences isolated from human colonic epithelial cells |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011045A1 A human lactoferrin produced by using an insect cell and method using the same |
| 02/15/2001 | WO2001011039A2 New sequence variants of the human 1-adrenoreceptor gene and use thereof |
| 02/15/2001 | WO2001011035A1 Monoclonal antibodies for human cytochrome p450 3a4 and human cytochrome p450 2c9 |
| 02/15/2001 | WO2001011034A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 02/15/2001 | WO2001011032A1 Secretory molecules |
| 02/15/2001 | WO2001011027A1 New protein |
| 02/15/2001 | WO2001011025A2 Crystallization and structure determination of staphylococcus aureus thymidylate kinase |
| 02/15/2001 | WO2001011024A2 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 02/15/2001 | WO2001011010A2 Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene |
| 02/15/2001 | WO2001011006A2 Detection of micro-organisms |
| 02/15/2001 | WO2001010910A1 Diagnostic method using expression of mn/ca9 protein in ascus pap smears |
| 02/15/2001 | WO2001010909A1 Diagnostic method using expression of mn/ca9 protein in agus pap smears |
| 02/15/2001 | WO2001010908A1 Ntr3, a member of the tnf-receptor supergene family |
| 02/15/2001 | WO2001010904A1 Map |
| 02/15/2001 | WO2001010903A2 Proteases and protease inhibitors |
| 02/15/2001 | WO2001010902A2 Nucleoc acids and secreted polypeptides encoded thereby |
| 02/15/2001 | WO2001010900A2 Globular assembly of amyloid beta protein and uses thereof |
| 02/15/2001 | WO2001010892A2 Peptide antagonists of factor viia |
| 02/15/2001 | WO2001010888A1 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis |
| 02/15/2001 | WO2001010886A2 Automated protein purification in the multiwell format by vacuum filtration |
| 02/15/2001 | WO2001010884A1 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene |
| 02/15/2001 | WO2001010881A1 Fluorogenic compounds and uses therefor |
| 02/15/2001 | WO2001010829A1 Novel vitamin d analogues |
| 02/15/2001 | WO2001010554A2 Laboratory robot and method and reagent kit for isolating nucleic acids |
| 02/15/2001 | WO2001010456A2 Peptides that block viral infectivity and methods of use thereof |
| 02/15/2001 | WO2001010444A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 02/15/2001 | WO2001010438A1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids |
| 02/15/2001 | WO2001010437A1 Methods of modulating matrix metalloproteinase activity and uses thereof |
| 02/15/2001 | WO2001010384A2 Method for identifying compounds for treatment of insulin resistance |
| 02/15/2001 | WO2001010205A1 Methods and materials relating to cd39-like polypeptides |
| 02/15/2001 | WO2001010203A2 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 02/15/2001 | WO2001010199A1 A knockout mouse for the tumor suppressor gene anx7 |
| 02/15/2001 | WO2000075361A3 Method to determine the toxicity caused by exposure to chemical and physical agents |
| 02/15/2001 | WO2000073496B1 Methods for quantitating the efficacy of oral care products |
| 02/15/2001 | WO2000071698A3 Mixture for neutralizing enzyme inhibitors |
| 02/15/2001 | WO2000068687A3 Methods of identifying therapeutic compounds in a genetically defined setting |
| 02/15/2001 | WO2000066709A3 Zymogen activation system |
| 02/15/2001 | WO2000066067A3 Ibd-associated microbial antigens and methods of using same |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000059933A3 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000052165A3 Compositions and methods for breast cancer therapy and diagnosis |